Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
3
×
life sciences
national blog main
biotech
cancer
clinical trials
san francisco blog main
san francisco top stories
abbvie
akouos
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amunix
andrew berens
anirvan ghosh
astrazeneca
avapritinib
biogen
blueprint medicines
bluerock therapeutics
boston
boulder/denver blog main
boulder/denver top stories
cancer diagnostics
cancer immunotherapy
cerovene
covid-19
crispr
deals
deciphera pharmaceuticals
deerfield management
detroit blog main
detroit top stories
durvalumab
editas medicine
europe blog main
europe top stories
fda
forty seven
What
announced
3
×
plans
3
×
cancer
medicine
acquisitions
approval
area
based
bay
bio
biopsy
blood
blueprint
buildout
ceo
chasing
close
collabs
company
covid
daniel
deadly
deal
deciphera
developing
drug
fda
filing
firm
forms
genomic
gi
gilead
gilead’s
help
introduce
ipo
liquid
lucence
medicines
Language
unset
Current search:
plans
×
announced
×
" boston blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow
@xconomy.com
5 years ago
Chasing Blueprint, Deciphera Plans FDA Filing for GI Cancer Drug